AlTi Global, Inc. (ALTI) delivered earnings and revenue surprises of -66.67% and 17.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AlTi Global, Inc. (ALTI) delivered earnings and revenue surprises of -66.67% and 17.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Howard Hughes Holdings (HHH) delivered earnings and revenue surprises of -51.43% and 19.89%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Moody's (MCO) delivered earnings and revenue surprises of 10.13% and 3.03%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Globe Life (GL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session. Enliven Therapeutics announced proof of concept data from Phase 1 clinical trial of ELVN-001 in chronic myeloid leukemia. Enliven Therapeutics shares surged 26% to $24.97 on Thursday. Here are some other big stocks recording losses in today’s session. Rallybio Corporation (NASDAQ: RLYB) shares gained 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Alpine Immune Sciences, ...
Shares of Nuvei Corp (NASDAQ: NVEI) rose sharply in today’s pre-market trading following a report indicating the company is in buyout talks with Advent International. Nuvei shares jumped 14.1% to $24.82 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Solidion Technology Inc. (NASDAQ: STI) shares gained 62.1% to $2.82 in pre-market trading after surging around 34% on Friday. The company, last week, announced the pricing of a $3.85 million private placement. JOANN Inc. (NASDAQ: JOAN) shares rose 42.6% to $0.3285 in pre-market trading. JOANN entered into an agreement to reduce debt and receive $132 million in new capital and related financial accommodations. Brand Engagement Network, Inc. (NASDAQ: BNAI) rose 47.7% to $15.60 in pre-market trading after jumping 40% on Friday. 2seventy bio, Inc. (NASDAQ: TSVT) climbed 31% to $5.24 in pre-market trading. The FDA Advisory Committee voted in favor of Bristol Myers Squibb's and 2seventy Bio's Abecma for triple-class exposed multiple myeloma in earlier lines of therapy. voxeljet AG (NASDAQ: VJET) gained 27.9% to $0.5999 in pre-market trading. ...
U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining by around 100 points on Monday. Shares of Logitech International S.A. (NASDAQ: LOGI) fell in today’s pre-market trading. Logitech announced the departure of CFO Chuck Boynton and reaffirmed its 2024 financial outlook. Logitech International shares declined 4.8% to $90.14in pre-market trading. Here are some big stocks recording losses in today’s pre-market trading session. B. Riley Financial, Inc. (NASDAQ: RILY) shares dipped 11% to $15.65 pre-market trading. B. Riley Financial failed to file its audited results after the end of extension ...
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Science Applications International Corporation (NASDAQ: SAIC) to report quarterly earnings at $1.43 per share on revenue of $1.64 billion before the opening bell, according to data from Benzinga Pro. SAIC shares rose 0.6% to $143.48 in after-hours trading. Analysts are expecting Comtech Telecommunications Corp. (NASDAQ: CMTL) to have ...
Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results. MercadoLibre reported quarterly earnings of $3.25 per share, unchanged from the same period last year. The company reported quarterly sales of $4.26 billion, beating the analyst consensus estimate of $4.12 billion. MercadoLibre shares dipped 9.6% to $1,643.30 on Friday. Here are some other stocks moving in today's mid-day session. Gainers AXT, Inc. (NASDAQ: AXTI) shares surged 74.4% to $3.9750 after the company reported better-than-expected fourth-quarter financial results. Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) shares jumped 60.8% to $8.22 after the company reported better-than-expected fourth-quarter financial results. AtlasClear Holdings, Inc. (NYSE: ATCH) rose 48% to $1.6899. EZFill Holdings Inc. (NASDAQ: EZFL) gained 44.6% to $ 1.8088. Ocean Biomedical, Inc. (NASDAQ: OCEA) jumped 42.3% to $0.7819. Gyre Therapeutics, Inc. (NASDAQ: GYRE) gained 36.2% to $21.79. Carvana Co. (NYSE: CVNA) rose 31.2% to $68.77 after the company reported fourth-quarter financial results. Sleep Number Corporation (NASDAQ: SNBR) gained 30.5% to $14.42 after the company reported better-than-expected fourth-quarter financial results. Also, Wedbush maintained a Neutral rating on the stock and raised its price target from $12 to $13.5. ATN International, Inc. (NASDAQ: ATNI) rose 26% to $ 35.72. Root, Inc. (NASDAQ: ROOT) gained 26% to $16.85 after the company reported better-than-expected fourth-quarter financial results. Following earnings, Cantor Fitzgerald upgraded the stock from Neutral to Overweight and raised its price target from $9 to $13. Infobird Co., Ltd (NASDAQ: IFBD) gained 25.7% to $3.72. Vroom, Inc. (NASDAQ: VRM) jumped 25.5% to $ 10.50. Vroom is expected to release fourth quarter earnings on March 13, 2024. ATN International, Inc. (NASDAQ: ATNI) rose 25.4% to $35.61. Intuitive Machines, Inc. (NASDAQ: LUNR) gained 22.4% to $10.14 after the company's Odysseus spacecraft landed on the Moon. Block, Inc. ...
U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday. Shares of NICE Ltd. (NASDAQ: NICE) rose sharply during Thursday’s session after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance above estimates. NICE reported fourth-quarter fiscal 2023 revenue growth of 9.6% year-over-year to $623.19 million, beating the consensus of $618.51 million. Adjusted EPS improved to $2.36 compared to $2.04 in the prior year, beating the consensus of $2.28. NICE shares jumped 10.4% to $249.39 on Thursday. Here are some other big stocks recording gains in today’s session. Root, Inc. (NASDAQ: ROOT) shares shares rose 40.8% to $12.21 after posting better-than-expected fourth-quarter results. Novavax, Inc. (NASDAQ: NVAX) gained 34.7% to $5.36. Novavax has reached a settlement related to the 2021 advance purchase agreement for Novavax's prototype Covid-19 vaccine (NVX-COV2373). Mativ Holdings, Inc. (NYSE: MATV) climbed 27.6% to $15.00 following upbeat earnings. Outset Medical, Inc. (NASDAQ: OM) rose 26% to $4.0680 following upbeat results. Ocular Therapeutix, Inc. (NASDAQ: OCUL) climbed 22.2% to $9.19 after announcing a $325.0 million private placement. Remitly Global, Inc. (NASDAQ: RELY) shares gained 19.5% to $21.13 after the company reported better-than-expected fourth-quarter ...
Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance. The company reported a Q4 adjusted loss of 11 cents per share, a turnaround from EPS income of $1.97 per share a year ago, missing the consensus for a loss of 5 cents per share. The insurer reported adjusted revenue of $25.73 billion, compared to $21.30 billion a year ago and the consensus of $25.55 billion. Humana shares dipped 11.3% to $356.93 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Onconetix, Inc. (NASDAQ: ONCO) shares surged 137% to $0.3519 after falling over 4% on Wednesday. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) gained 97% to $4.0527 after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine. Enviva Inc. (NYSE: EVA) climbed 47.4% to $0.5239. Vera Therapeutics, Inc. (NASDAQ: VERA) shares jumped 46% to $24.84 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target. Rail Vision Ltd. (NASDAQ: RVSN) gained 43.8% to $7.78. Foresight's affiliate Rail Vision's Main Line System secured EU Railway Standards approval and certifications. LAVA Therapeutics N.V. (NASDAQ: LVTX) rose 37.4% to $2.13 after the company announced a clinical trial collaboration and supply agreement with Merck & Co. to evaluate LAVA-1207 in combination with KEYTRUDA. Acutus Medical, Inc. (NASDAQ: AFIB) shares climbed 30.6% to $0.29. Acutus Medical has been granted European patent number EP3043701 titled "Devices and Methods for Determination of Electrical Dipole Densities on a Cardiac Surface (And Methods for Diagnosing Tissue Health)." Prairie Operating Co. (NASDAQ: PROP) gained 28.8% to $8.17. American Superconductor Corporation (NASDAQ: AMSC) shares climbed 28.4% to $12.52 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates. CCSC ...
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Shares of Alaska Air Group, Inc. (NYSE: ALK) rose during Thursday’s session following upbeat earnings. Alaska Air Group reported fourth-quarter operating revenue of $2.55 billion, up 3% Y/Y, in-line with the consensus of $2.55 billion. The company reported adjusted EPS of $0.30, down from $0.92 a year ago, beating the consensus estimate of $0.18. Alaska Air Group shares rose 5.5% to $37.78 on Thursday. Here are some other big stocks recording gains in today’s session. Vera Therapeutics, Inc. (NASDAQ: VERA) shares jumped 40.2% to $23.86 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price ...